Masked Taper With Behavioral Intervention for Discontinuation of Benzodiazepine Receptor Agonists: A Randomized Clinical Trial

By sjmartinez • October 8, 2024

Fung CH, Alessi C, Martin JL, Josephson K, Kierlin L, Dzierzewski JM, Moore AA, Badr MS, Zeidler M, Kelly M, Smith JP, Cook IA, Der-Mcleod E, Ghadimi S, Naeem S, Partch L, Guzman A, Grinberg A, Mitchell M. Masked Taper With Behavioral Intervention for Discontinuation of Benzodiazepine Receptor Agonists: A Randomized Clinical Trial. JAMA Intern Med. 2024 Oct 7:e245020. doi: 10.1001/jamainternmed.2024.5020. Epub ahead of print. PMID: 39374004; PMCID: PMC11459364.

Tags: Geriatrics, Publications, Pulmonary, Critical Care & Sleep Medicine, Veterans Administration

Association between exposure to air pollution and age at natural menopause: The Study of Women’s Health Across the Nation

Jang H, Harlow SD, Zhang W, Reeves A, Ebisu K, Wu X, Gold EB, Derby CA, Kravitz HM, Greendale GA, Schwartz J, Park SK. Association[...]

Probing effect modification by socioeconomic status in associations between blood biomarkers of neuropathology and cognitive outcomes in the United States and India

Nichols E, Kim JK, Aksman LM, Gross AL, Hu P, Kobayashi LC, Thyagarajan B, Lee J, Crimmins EM. Probing effect modification by socioeconomic status in[...]

Dextromethorphan Hydrobromide-Bupropion Hydrochloride for Agitation in Dementia: Combination or Two Stand-Alone Drugs

Brown EE, Semla T, Reuben DB. Dextromethorphan Hydrobromide-Bupropion Hydrochloride for Agitation in Dementia: Combination or Two Stand-Alone Drugs. J Am Geriatr Soc. 2026 Aug 7.[...]